KDM1A can apparently inhibit the expression of TIMP1 by demethylating H3K4ME2 in the TIMP1 promoter region, activating MMP9, which is responsible for tumor migration and PTC invasion through this pathway (Zhang et al., 2019). Here, MMP9 is linked to neoplasm.